Nexavar (sorafenib)
pCPA File Number:
20812
Negotiation Status:
Negotiations were not pursued
Indication(s):
Metastatic Progressive Differentiated Thyroid Carcinoma
Sponsor/Manufacturer:
Bayer Inc.
CDA-AMC Project Number:
PC0049-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: